Asia-Pacific STD diagnostics market is growing at a CAGR of around 9.4% during the forecast period. The region has the second-highest HIV prevalence. Major countries such as China, India and Indonesia account for around three-quarters of the total number of people living with HIV. There is a huge variation across the region in terms of the incidence of HIV and countries’ responses to the diagnosis and treatment. However, investments by countries with HIV diagnosis and treatment in the region have doubled over the last decade.
Visit for Global Sexually Transmitted Diseases (STD)
Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/sexually-transmitted-disease-market-size
There is a significant increase in the incidence and prevalence of genital herpes and genital warts in the region. Gonorrhea is the most dominant STD in the region, with a high incidence of chromosomally-mediated resistant and penicillinase-producing strains comprising around 35%-50% of isolates. Clinical treatment failures due to spectinomycin-resistant gonococci are increasing in the APAC region. Uncontrolled antibiotic sales are responsible for these resistant strains. Further, STDs such as syphilis incidence was declined in 1950, however, it has re-emerged in the APAC region. The incidence of Cancroid is decreasing, while herpes is making up a greater share in the ulcer disease. The high incidence of STDs in this area is an indication of future trends of HIV/AIDS in the APAC region. The Asia-Pacific STD diagnostics market is strongly fueled by the rapid spread of human papilloma virus infection among the female population.
In addition, supportive government initiatives and prevention programs are impacting the growth of Asia-Pacific STD diagnostics market as it has succeeded in reducing new HIV infections across the region. However, late diagnosis remains a key area of concern. Many countries in APAC have disciplinary and stigmatizing laws in place, which prevent members of key affected individuals from accessing services and work to support HIV stigma. According to UNAID (Joint United Nations Program on HIV/AIDS), in 2018, there were approximately 310,000 new infections in the region. The progress in reducing new infections has slowed in recent years and new HIV infections are on the rise in some countries of the region.
Research Methodology
The market study of the Asia-Pacific STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific STD Diagnostics Market by Disease Type
5.1.1. Chlamydia
5.1.2. Syphilis
5.1.3. Gonorrhea
5.1.4. Herpes Simplex Virus (HSV)
5.1.5. Human Papilloma Virus (HPV)
5.1.6. Human Immunodeficiency Virus (HIV)
5.1.7. Others
5.2. Asia-Pacific STD Diagnostics Market by Product
5.2.1. Laboratory Testing Devices
5.2.2. Point-of-Care (POC) Testing Devices
5.3. Asia-Pacific STD Diagnostics Market by End-user
5.3.1. Hospitals and Clinics
5.3.2. Diagnostic Centers
5.3.3. Homecare
6. Regional Analysis
6.1. China
6.2. India
6.3. Japan
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie Inc.
7.3. Becton, Dickinson and Co.
7.4. Biocartis NV
7.5. Bio-Rad Laboratories, Inc.
7.6. Danaher Corp.
7.7. Eli Lilly and Co.
7.8. F. Hoffmann-La Roche Ltd.
7.9. Merck KGaA
7.10. Thermo Fisher Scientific, Inc.
1. ASIA-PACIFIC STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2018-2025 ($ MILLION)
2. ASIA-PACIFIC STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
3. ASIA-PACIFIC STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
4. ASIA-PACIFIC STD DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
1. ASIA-PACIFIC STD DIAGNOSTICS MARKET SHARE BY BIOMARKER DISEASE TYPE, 2018 VS 2025 (%)
2. ASIA-PACIFIC STD DIAGNOSTICS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
3. ASIA-PACIFIC STD DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)
4. ASIA-PACIFIC STD DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
5. CHINA STD DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. INDIA STD DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. JAPAN STD DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. REST OF ASIA-PACIFIC STD DIAGNOSTICS MARKET SIZE, 2018-2025 ($ MILLION)